Xeris Biopharma Holdings, Inc. XERS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s current ratio?
- Xeris Biopharma Holdings, Inc. (XERS) reported current ratio of 2.1× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s current ratio changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s current ratio increased by 23.4% year-over-year, from 1.7× to 2.1×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s current ratio has grown at a -16.5% compound annual growth rate (CAGR), from 5.4× to 2.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.